Mist1 is an exocrine-specific transcription factor that is necessary for the establishment of cell organization and function of pancreatic acinar cells. While Mist1 is not expressed in the endocrine pancreas, the disorganized phenotype of the exocrine component may affect endocrine function. Therefore, we examined endocrine tissue morphology and function in Mist1-knockout (Mist1 KO ) mice. Endocrine function was evaluated using a glucose-tolerance test on 2-10-month-old female mice and revealed a significant reduction in glucoseclearing ability in 10-month-old Mist1 KO mice compared with wild-type mice. Immunohistochemical analysis of islet hormone expression indicated that the decreased endocrine function was not due to a decrease in insulin-, glucagon-or somatostatin-expressing cells. However, a decrease in the size of islets in 10-month-old Mist1 KO mice was observed along with a decrease in Glut-2 protein accumulation. These results suggest that the islets in Mist1 KO mice are functionally compromised, likely accounting for the decreased glucose tolerance. Based on these findings, we have identified that the loss of a regulatory gene in the exocrine compartment can affect the endocrine component, providing a possible link between susceptibility for various pancreatic diseases.
Introduction
The pancreas originates from the foregut endoderm at approximately embryonic day (E) 8·5 when signals from the mesoderm commit cells to a pancreatic fate (Gittes & Rutter 1992) . By approximately E13·5, the division of pancreatic precursor cells into either acinar, islet or duct cells is apparent morphologically (Slack 1995) . The differentiation of these cells is regulated by the correct temporal and spatial expression of a series of transcription factors that direct pancreatic commitment to either an exocrine or endocrine fate (reviewed by Edlund 2001) . The earliest expressed transcription factor that is necessary for both pancreatic cell lineage commitment and islet cell differentiation is pancreas duodenum homeobox 1 (Pdx1; Jonsson et al. 1994) . Pdx1 plays an essential role in pancreatic branching, differentiation and maintenance of insulin-secreting -cells (Offield et al. 1996 , Holland et al. 2002 . Other key transcription factors that are integral to pancreatic development include pancreas transcription factor 1, p48 subunit (PTF1-p48, PTF1a; Krapp et al. 1996) and neurogenin 3 (Gradwohl et al. 2000) , which contribute to exocrine-and endocrine-specific differentiation, respectively (Kim & MacDonald 2002) .
Although the endocrine and exocrine components are delineated early in development and they are morphologically and functionally distinct, their coexistence involves complex paracrine interactions that affect pancreatic cell function and disease. For example, insulin potentiates acetylcholine-induced amylase release in rat pancreatic acini, possibly due to an effect on intracellular free calcium levels in pancreatic exocrine cells (Singh & Adeghate 1998) . Cholecystokinin octapeptide (CCK-8) can help to regenerate exocrine tissue in cases of pancreatitis, but insulin is required for this regeneration as diabetic rats do not possess CCK-8-mediated regenerative ability. In these diabetic rats, administration of exogenous insulin restores regenerative ability (Hegyi et al. 2004) . Alternatively, the development of pancreatitis, which results in the destruction of the exocrine parenchyma and increased inflammation, contributes to eventual destruction of the endocrine parenchyma (Sarles et al. 1990 ). This destruction leads to endocrine insufficiency in 60% of pancreatitis patients (Dimagno & Dimagno 2004) . Even improper development in one compartment can affect the outcome of the other compartment, as observed following deletion of either exocrine (PTF1a) or endocrine (BETA2)-specific transcription factors (Krapp et al. 1998 , Naya et al. 1997 ).
Recently we have been characterizing a mouse model of exocrine pancreatic disease. These mice carry a genespecific deletion for Mist1, an exocrine-specific transcription factor belonging to the basic helix-loop-helix family of proteins (Lemercier et al. 1997) . Mist1 is initially expressed in the pancreas beginning at approximately E10·5 and persists to high levels in the adult pancreas (Pin et al. 2000) . Characterization of Mist1 expression in adult tissues reveals a restricted pattern exclusive to cells with an exocrine function. Mist1-knockout (Mist1 KO ) animals exhibit defective acinar cell organization and impaired function, and by 12 months of age, they develop pancreatic lesions similar to those found in chronic pancreatitis (Pin et al. 2001) . At the functional level, Mist1 KO mice exhibit deficits in cell communication (Rukstalis et al. 2003) , acinar cell development (Johnson et al. 2004) , calcium homeostasis and regulated exocytosis (Luo et al. 2005) .
Due to the defects in exocrine cell function and morphology, we hypothesize that the alteration in exocrine pancreas function of Mist1 KO mice leads to altered function of the endocrine pancreas. To examine this, functional and morphological analysis of endocrine tissue was conducted in young (2 months), adult (3-5 months) and old (10 months) Mist1 KO mice. We observed that 10-month-old Mist1 KO mice were intolerant to highglucose challenge with a significantly smaller islet size, suggesting that exposure to chronic exocrine pancreas deficiency causes an adverse affect on the endocrine component of the pancreas. Interestingly, immunofluorescence (IF) and Western-blot analysis for a -cell-specific glucose transporter 2 (Glut-2; Guillam et al. 1997) indicates a significant loss of this protein as early as 2 months. This result suggests that the islets in Mist1 KO mice are functionally compromised, which may, over time, contribute to functional endocrine defects.
Materials and Methods

Mice
All mice in this study were derived from matings between C57/BL6 mice and SvJ129 mice. Progeny carried a single gene replacement of the Mist1 coding region with the bacterial lacZ gene (Pin et al. 2001) . Heterozygous mice for the Mist1 allele (Mist1 LacZ ) were back-crossed to C57/BL6 mice for at least seven generations producing an average C57/BL6 background purity of 99·6%. The resulting matings generated the wild-type (WT) and Mist1 KO (both Mist1 alleles replaced) mice used in these studies. All experiments using mice were approved by the animal care committee at the University of Western Ontario and mice were handled according to regulations stipulated by the Canadian Council on Animal Care.
Glucose-tolerance and plasma insulin ELISA analysis
Female mice (2-10 months old) were fasted overnight and blood glucose levels were measured prior to intraperitoneal administration of 2 g/kg -glucose (t=0). Following injection, blood glucose levels were monitored at t=10, 20, 40, 60, 90 and 120 min post-injection using tail blood with a Fast-Take Glucosemeter (Lifescan, Burnaby, British Columbia, Canada). Area under the curve (AUC) represents absolute glucose tolerance and was calculated for the glucose-tolerance profile of each mouse using the trapezoidal method (Allison et al. 1995) . Pancreata were dissected and immediately processed for immunohistochemistry and protein extraction.
To measure plasma insulin levels, mice were killed 5, 20 or 120 min after glucose administration and blood obtained through cardiac puncture. Serum insulin was determined from 10-month-old WT and Mist1 KO mice as per the manufacturer's protocol using a Mercodia Ultrasensitive (0-6·5 µg/l) mouse insulin ELISA kit (ALPCO Diagnostics, Windham, New Hampshire, USA). At this time, pancreatic tissue was dissected and weighed. Relative pancreatic size was determined as a percentage of total mouse body weight. To determine the overall amount of endocrine tissue within the pancreas, the weight of the pancreas was multiplied by the percentage of endocrine tissue determined by microscopic morphometric analysis (see below).
Immunofluorescence for pancreatic proteins
For developmental analysis, whole embryos were obtained from timed matings based on the presence of a vaginal plug (marked as E0·5). For adult studies, pancreata were dissected from WT and Mist1 KO female mice and embedded in Cryomatrix (Fisher) as previously described (Pin & Merrifield 1997) . Using a Shandon cryostat, tissues were cut into 6 µm sections, mounted onto slides (Fisher) and stored at 20 C until use. Sections were first fixed with 4% formaldehyde, and permeabilized with 0·1% Triton X-100 for 10 min. Sections were blocked (5% BSA in 0·1% Triton X-100) then incubated for 1 h with primary antibodies, including rabbit anti-amylase (1:1000; Calbiochem), mouse anti-insulin (1:500; Sigma), rabbit anti-glucagon (1:100; Sigma), rabbit anti-pdx1 (1:1000; a generous gift from Dr C. Wright, Vanderbilt University, Nashville, Tennessee, USA), rabbit anti-Glut-2 (1:500; Chemicon), rabbit anti-somatostatin (1:50; Chemicon) and rabbit anti-Mist1 (1:1000; Pin et al. 2001) . In some cases, dual labeling was performed by co-incubating insulin-specific antibodies with glucagon-, Glut-2-, somatostatin-or pdx1-specific antibodies. Tissue was washed three times in PBS and incubated in secondary antibodies (1:100 of goat anti-mouse tetramethylrhodamine -isothiocyanate (TRITC) or goat anti-rabbit fluorescein isothiocyanate (FITC; Sigma). For double labeling, secondary antibodies were combined in a single incubation. Tissue was washed three times in PBS followed by a 5-min incubation in DAPI (1:1000), and slides mounted with Vectashield (Vector Laboratories, Burlingame, CA, USA). Cell counting for insulin, glucagon and Glut-2 was performed by counting the cells of 10 islets for WT (n=4) and Mist1 KO (n=4) sections.
BrdU staining
Paraffin sections of mouse pancreata were cleared with two 5-min treatments with toluol followed by a graded series of ethanol washes. A methanol/H 2 O 2 mixture was used to clear sections of any peroxidase activity and then sections were rinsed with distilled water. Two 3-min PBS washes were followed by incubation with a protease solution (0·05% protease in 0·5 M Tris buffer at pH 7·5 or 0·1% trypsin in PBS, pH 7·8) for 5 min at 37 C. To stop the protease reaction distilled water was added, followed by two 3-min washes with PBS. A 30-min 37 C incubation in 2 M HCl was followed by two 5-min washes in borate buffer (0·1 M Na 2 B 4 O 7 , pH 8·5). Tissue sections were then washed in 1 PBS and incubated with a mouse monoclonal anti-BrdU (Sigma) antibody overnight at 4 C. Slides were washed in PBS and then incubated with goat anti-mouse Ig/Biotin (Jackson Laboratories) for 30 min at room temperature. Sections were washed with PBS and incubated in streptavidin ABC/horseradish peroxidase solution (Dako) for 30 min. This step was followed by washing the slides and developing the sections with diaminobenzidine (7 mM diaminobenzidine and 0·3% H 2 O 2 in PBS) for 5 min. CuSO 4 was used for another 5 min and then slides were washed in running tap water for 5 min to stop enzyme activity.
Islet analysis
Cryostat sections were stained with either hematoxylin and eosin or dual IF for insulin/glucagon. Quantitative evaluation was performed using computer-assisted image analysis with OpenLab 4·0 Modular Software for Scientific Imaging (Improvision). Under low magnification (50 ) the area of the pancreas was manually traced using Openlab software, excluding large blood vessels and connective tissue accumulations. At higher magnification (400 ), individual islets were identified by insulin/glucagon staining, and manually traced. In total, nine random sections were chosen and the islets counted and measured. For each animal, at least 19 islets were assessed with a median of 32 islets measured. Analysis parameters included total number of islets per unit area of pancreas, total percentage of endocrine tissue area per whole pancreas area, and number of insulin-and glucagon-expressing cells per islet.
Western blotting and densitometry
Tissue-protein extraction, protein electrophoresis and immunoblotting were performed as described previously (Johnson et al. 2004) . For immunoblot analysis, 40 µg of WT and Mist1 KO pancreatic protein was loaded onto a 12% SDS/PAGE gel. Proteins were transferred to a PVDF membrane by semi-dry transfer, and probed with rabbit anti-Glut-2 (1:2500 in 5% non-fat dried milk; Chemicon) for 1 h. Blots were rinsed three times in PBS and incubated with anti-rabbit horseradish peroxidaseconjugated secondary antibody (1:2000 in 5% non-fat dried milk, Sigma). Following a second series of washes, the membrane was incubated with LumiGlo chemiluminescent substrate (Mandel Marketplace), exposed to film (Kodak) and developed. Densitometry was performed on Western-blot autoradiographs for 2-(n=4) and 10-month (n=6) WT and Mist1 KO protein samples. Autoradiographs were analysed using a Fluorochem 8800 documentation system and accompanying Fluorochem 8800 software (Alpha Inotech, San Leandro, CA, USA).
Statistical analyses
Data are expressed as means S.E.M All statistical analyses were performed using Graphpad Prism 4·02 for Windows (GraphPad Software, San Diego, CA, USA). For comparison between two groups, the paired Mann-Whitney U test was used, where significance was obtained if P<0·05. Glucose-tolerance time courses were statistically analysed using two-way repeated-measures analysis of variance (ANOVA) and a Bonferroni post-hoc test.
Results
Glucose tolerance and insulin secretion in WT and Mist1
KO mice
Our previous analysis of Mist1 expression in the adult pancreas indicated specific expression limited to acinar cells (Pin et al. 2000) . To confirm this restriction in expression during pancreatic development, pancreatic sections were obtained from E16·5 WT mice and analyzed for Mist1, amylase and insulin expression using IF (Fig. 1) . As expected, Mist1 expression was localized to the nuclei of cells outside of the developing endocrine compartment (Fig. 1A) . This expression corresponds directly with exocrine tissue based on amylase expression (Fig. 1C) , whereas Mist1 and insulin were not co-expressed ( Fig. 1D and E).
The altered exocrine morphology and increased exocrine tissue damage that occurs in the absence of Mist1 (Pin et al. 2001) suggests that a possible defect in endocrine function may exist. To address this possibility, a glucosetolerance test was performed on 2-, 4-and 10-month-old WT and Mist1 KO animals (Fig. 2) . Fasting blood glucose levels in 2-month-old animals were not significantly different between WT and Mist1 KO mice (n=7; Fig. 2A,  t=0) . After glucose challenge, a peak blood glucose level was reached 10 min post-glucose stimulation in both WT and Mist1 KO groups (14·9 1·38 and 15·1 0·95 mmol/l, respectively). There was no significant difference in blood glucose levels between the groups at any time point following administration of glucose, indicating a similar ability to respond to increased glucose concentration in 2-month-old WT and Mist1 KO animals. This was confirmed by measuring the AUC for the glucose-tolerance time course (Fig. 2B) , which indicated equivalent glucose-clearing capacity.
Since there is a progressive increase in the severity of the exocrine phenotype of Mist1 KO mice with age (Pin et al. 2001) , glucose tolerance was assessed in 4-and 10-monthold animals. No significant difference was observed in 4-month-old animals ( Fig. 2C and D) , either in fasting glucose levels or following glucose injection, as illustrated by the similar profiles of the glucose-tolerance curves for WT and Mist1 KO mice (n=6; Fig. 2C ). Fasting blood glucose levels in 10-month-old mice revealed no difference between WT and Mist1 KO animals (Fig. 2E, t=0 ). Following glucose injection, peak blood glucose levels were obtained within 10-20 min for both groups. At 10 min post-glucose stimulation, blood glucose levels were significantly higher (P<0·05) in Mist1 KO animals (15·9 1·0 mmol/l) compared with WT mice (12·9 1·2 mmol/l). This difference remained at 20 min, where the average blood glucose level in WT mice (13·2 1·4 mmol/l) was significantly lower (P<0·03) than Mist1 KO levels (19·4 1·5 mmol/l). The higher blood glucose levels in Mist1 KO mice persisted at 40 min post-stimulation when Mist1 KO glucose levels reached 16·0 1·0 mmol/l in contrast to 11·3 1·1 mmol/l attained by WT mice. By 60 min, WT and Mist1 KO animals displayed similar blood glucose levels. AUC determination confirmed that absolute blood glucose tolerance in Mist1 KO mice was significantly less than that of WT mice, indicating a decreased glucoseclearing capacity in Mist1 KO animals (P<0·005; Fig. 2F ). A delayed response in glucose clearance from blood could suggests deficits in insulin secretion. Therefore, the plasma insulin levels were assessed at 5, 20 and 120 min following glucose stimulation in 10-month-old mice. At 5 min post-glucose administration there was a significant (P<0·05) difference observed between WT and Mist1 KO animals (Fig. 2G) . WT mice exhibited insulin levels that were approximately double that observed in Mist1 KO animals (1·92 0·28 (n=5) versus 0·87 0·1 µg/l (n=6)). At 20 min post-stimulation (Fig. 2H) , Mist1 KO mice exhibited higher serum insulin levels than their WT counterparts (3·24 1·03 and 2·23 0·55 µg/l respectively; n=5) that was not statistically different. At the experimental endpoint of 120 min post-glucose exposure (Fig. 2I) , Mist1 KO mice serum insulin levels (1·17 0·23 µg/l; n=8) were significantly higher (P<0·03) than the levels observed in WT animals (0·36 0·15 µg/l; n=7).
Islet morphology in WT and Mist1
KO pancreas
Due to a change in the ability of Mist1 KO mice to efficiently reduce blood glucose levels, general islet morphology was compared between WT and Mist1 KO mice in 2-and 10-month-old mice (Fig. 3 Fig. 3A) . However, at 10 months of age Mist1 KO mice exhibited a significantly higher islet density when compared with WT mice (0·82 0·08 versus 0·49 0·07 islets/mm 2 ; n=13; P<0·05; Fig. 3B ). Analysis of islet size in 10-month-old mice indicated that the average islet size in WT mice was greater than that in Mist1 KO tissue (12950 1557 versus 9827 1002 µm; Fig. 3C ). This difference was not statistically significant, which is likely due to the large variability in islet size found in Mist1 KO pancreatic tissue (Fig. 3D-F) . Comparison of total endocrine area revealed a modest increase in the overall amount of endocrine tissue within the pancreata of 10-month-old Mist1 KO mice with no significant difference observed (Table 1) . To determine whether the increase in islet density is due to more islets in Mist1 KO mice, the wet weight of the pancreas was compared between WT and Mist1 KO mice. At 2 months of age, there is no difference in relative pancreatic weight (Fig. 3 G) . At 10 months of age there is a significant decrease in the relative pancreatic weight of Mist1 KO mice (0·37 0·02%; n=17) compared with WT mice (0·54 0·03%; n=15; Fig. 3H (Fig. 4) . No obvious alterations were observed in the expression of pdx1 ( Fig. 4B and E) , as in all cases its expression was limited to the nuclei of insulin-positive -cells ( Fig. 4C and F) . Similarly, there was no alteration in the expression of insulin (Fig. 4A, D,   Figure 2 Mist1 KO mice exhibit decreased glucose tolerance at 10 months. In 2 (A; n=7) and 4 (C; n=6)-month-old animals, no differences in the blood glucose levels were observed between WT (♦) and Mist1 KO () animals at any time point after glucose injection. However, 10-month-old Mist1 KO mice (E) exhibited significantly higher blood glucose levels when compared with WT counterparts at t=10, 20 and 40 min (*, P<0·05) after administration of glucose. By t=60 min both WT (n=16) and Mist1 KO (n=22) mice exhibited similar blood glucose levels. Analysis of the AUC corroborates a decreased tolerance (*, P<0·05) only in 10-month-old Mist1 KO mice (F) with no difference at 2 (B) and 4 months (D) from WT littermates. Plasma insulin levels were analyzed in 10-month-old animals at 5 (G), 20 (H) and 120 (I) min post-glucose exposure. At 5 min, there was significantly less serum insulin in Mist1 KO mice compared with WT mice (*, P<0·05). By 20 min post-glucose exposure, Mist1 KO mice exhibited a trend toward higher serum insulin levels than WT counterparts that reaches significance at the experimental endpoint of 120 min (*, P<0·05). All results are shown S.E.M. Fig. 4H and K) (Fig. 4 M) . Additionally, there was no observable difference in the localization of -cells between WT and Mist1 KO islets (data not shown). The change in the size of islets within Mist1 KO pancreata could suggest differential turnover of -cells within the tissue. Therefore, we injected Mist1 KO and WT mice with BrdU and assessed the percentage of proliferating cells within the pancreatic islet tissue, using immunohistochemical analysis for BrdU incorporation (Fig. 4N, Table 1 ). In WT mice 2·5 0·6% of all islet cells were BrdU-positive and in Mist1 KO mice 2·1 0·4% of all islet cells were BrdU-positive, suggesting no significant change in the islet cell-turnover rate.
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Glut-2 analysis
The decreased ability to clear glucose, coupled with the smaller islet size suggests that the islets in Mist1 KO mice are functionally compromised. Therefore, the expression of Glut-2 was examined in both WT and Mist1 KO animals to assess one functional component of glucose sensing in -cells. IF for Glut-2 revealed expression in 2-month-old WT (Fig. 5B ) and Mist1 KO (Fig. 5E ) islets. In 10-monthold mice, Glut-2 protein was readily observed in WT mice (Fig. 5H) but was difficult to observe in -cells of Mist1 KO islets (Fig. 5K) . While lower magnifications make it hard to visualize Glut-2 expression in Mist1 KO islets, at higher magnifications trace amounts of Glut-2 expression were observed (Fig. 5N) . To confirm this decrease in Glut-2 accumulation, Western-blot analysis was performed on KO mice exhibit a significantly higher number of islets per unit area than their WT counterparts (*, P<0·05; n=12). (C-F) However, a decrease in islet size was observed in hematoxylin-and eosin-stained sections of pancreatic tissue from 10-month-old Mist1 KO animals (E, F) compared with WT mice (D); see also (C). I, islets; *, small islets. These observations are supported by measuring islet area using OpenLab 4·0 software, and suggest a decreased average islet size in Mist1 KO pancreatic tissue compared with WT islets at 10 months of age (n=12) KO , n=4) . Analysis showed that there is a decrease in Glut-2 levels in 2-month-old Mist1 KO mice similar to that found in female 2-month-old Mist1 KO mice (Fig. 6E) , ruling out any gender exclusivity. These results indicate that the effects on islet protein expression precede the functional deficit observed in the Mist1 KO mice. To understand whether the deficiency in Glut-2 expression is due to a decrease in the number of Glut-2-expressing cells, a decrease in Glut-2 expression within in each cell, or a combination of both, we manually counted the percentage of Glut-2-positive cells within the islets of WT and Mist1 KO pancreatic tissue (Fig. 6F) . Cell counting followed by a paired Mann-Whitney U test illustrated that there is a significant decrease in the percentage of Glut-2-positive cells in Mist1 KO islets versus WT islets, with 70·0 1·8 and 76·8 1·5% of cells staining, respectively (P<0·05). However, this difference does not account for the 80-90% reduction in Glut-2 expression in Mist1 KO tissue. Therefore, while there may be a decrease in the number of Glut-2-positive cells in Mist1 KO pancreata, it appears that Mist1 KO -cells accumulate Glut-2 to lower levels than WT -cells.
Finally, to determine whether the loss of Glut-2 was a primary defect in Mist1 KO pancreatic tissue, the expression of Glut-2 was compared between WT and Mist1 KO tissue through postnatal development. Protein extracts were obtained from tissue at postnatal days 1, 8 and 22 and compared by Western-blot analysis. At these postnatal time points, equivalent amounts of Glut-2 protein are consistently observed. Since alterations in exocrine cell organization (Johnson et al. 2004 ) and gene expression (Rukstalis et al. 2003 ) are observed at birth in Mist1 KO mice, the loss of Glut-2 expression is a secondary defect in Mist1 KO mice.
Discussion
In this study, we have identified deficiencies in the endocrine pancreas that are brought on by deletion of the exocrine-specific transcription factor, Mist1. Older Mist1 KO mice exhibit deficits in pancreatic and islet size, glucose tolerance and insulin secretion. IF analysis suggests that the islets in Mist1 KO mice are functionally compromised due to a significant reduction in the expression of the glucose transporter, Glut-2, in adult -cells. Importantly, while the functional defects in insulin response may not be apparent in younger Mist1 KO animals, the islets within these animals exhibit changes in Glut-2 protein expression that occur after weaning but prior to 2 months of age. The timing of decreased Glut-2 expression suggests that this is a secondary defect in the Mist1 KO phenotype, occurring after the cellular disorganization observed in acinar cells. These results implicate exocrine pancreas dysfunction as a factor for defects in endocrine tissue morphology and function.
The decreased endocrine function observed in 10-month-old Mist1 KO mice was illustrated by the comparison of both glucose tolerance and insulin secretion to WT mice. Significantly higher levels of plasma glucose were observed following intraperitoneal (IP) injections, possibly reflecting defects in glucose sensing leading to a delayed release of insulin. The first phase of glucose simulated insulin secretion (GSIS) normally proceeds with a peak serum insulin levels occurring 5 min post-glucose stimulation (Curry et al. 1968) . Peak levels are reached this quickly since the -cell's first response is to release all stored insulin to combat elevated blood glucose levels (Wollheim et al. 1980 , Del Prato et al. 2002 . The second phase of GSIS follows at approximately 20 min postglucose exposure and can persist until blood glucose levels Figure 6 The decrease in Glut-2 expression predates endocrine deficiency in Mist1 KO mice. Western-blot analysis indicates that at both 10 (A) and 2 months (C) Glut-2 expression is readily observed in all WT samples with faint or no Glut-2 expression in Mist1 KO pancreatic extracts. Protein loading was evaluated through Coomassie Brilliant Blue staining of equivalently loaded gels. Individual band densitometry reveals a significant decrease in band intensity in 10-(B) and 2-month Mist1 KO mice (D; P<0·01). (E) Western-blot analysis with male 2-month pancreatic protein samples shows that the decrease in Glut-2 expression was not limited to female mice. (F) Individual cell counts highlight that there was a significant decrease (*P<0·05) in the number of islet cells that express Glut-2 in 10-month are normalized (Grodsky & Bolaffi 1992) . Peak serum insulin levels in phase 2, however, do not reach those attained in phase 1 since this phase relies on the inherent ability of the -cell to produce insulin, not release stored quantities (Wollheim et al. 1980) . We observed drastically decreased serum insulin levels in 10-month Mist1 KO mice compared with WT counterparts 5 min post-glucose exposure, which suggests a general delay in the onset of insulin release. At 20 min post-glucose stimulation, Mist1 KO mice have recovered to attain serum levels equivalent to WT levels. It is at approximately this time point where insulin secretion is able to commence through the delayed sensing of glucose. By 120 min post-glucose stimulation, the average plasma insulin level in Mist1 KO mice was significantly higher than that of WT mice, even though the blood glucose level at this time point is similar to that of WT animals. While perfusion experiments would be ideal to fully assess alterations in GSIS in these mice, this time-point analysis suggests that the phase 1 GSIS in 10-month-old Mist1 KO mice is compromised and that their ability to store or release stored insulin is altered. The observed increase in plasma insulin at 120 min may be compensatory for a deficiency in early insulin release.
Deficits in glucose tolerance and insulin secretion could be due to a decrease in islet mass relative to total body weight. The pancreatic weight for Mist1 KO mice is 68% of that seen in their WT counterparts, a difference that was seen for both female (Fig. 3 ) and male (data not shown) mice, indicating that this alteration is not gender specific. Taking into consideration the increase in endocrine tissue per pancreatic area, this translates into a 20% decrease in overall islet mass. However, studies involving partial pacreatectomy suggest that even a 60% loss of islet mass does not cause glucose intolerance (Anneren 2002) , making it unlikely that the modest decrease in islet mass is the cause of endocrine defects in Mist1 KO mice. We would suggest that the decrease in Glut-2 expression is the underlying cause for the decreased glucose tolerance in 10 month Mist1 KO mice. Glut-2 is a glucose-sensing and -transporting molecule located on the surface of -cells. Homozygous deletion of Glut-2 (solute carrier family 2 member 2, slc2a2) results in alterations in the postnatal development of pancreatic islets and increases susceptibility to hyperglycemia, relative hypoinsulinemia, abnormal glucose tolerance and decreased glucose-stimulated insulin gene expression. Interestingly, Glut-2-null mice exhibit a loss of first-phase GSIS, but the second phase of GSIS remains unaffected (Guillam et al. 1997) . These observations are all consistent with the phenotypes observed in Mist1 KO mice, suggesting that alterations in -cells may be the result of a loss of Glut-2 expression and not the reverse scenario. In addition, the absence of Glut-2 has been observed in different animal models of diabetes (Jorns et al. 1996 , Bonny et al. 1997 . It is unclear why the decrease in Glut-2 expression at 2 months does not alter glucose clearance. One possible explanation is that a threshold level of Glut-2 is required for proper glucose tolerance. At 2 months this threshold may still be exceeded, whereas by 10 months Glut-2 levels may fall below the required threshold resulting in aberrant -cell function and altered glucose tolerance. In support of this theory, Glut-2 heterozygous mice, which only have a single copy of the Glut-2 gene, exhibit no alterations in glucose tolerance (Guillam et al. 1997) .
The loss of Glut-2 expression in Mist1 KO -cells over time suggests intriguing cross-talk between exocrine and endocrine compartments in which the deletion of an exocrine-specific transcription factor results in the decreased expression of an endocrine-specific protein.
While we cannot absolutely exclude the possibility that Mist1 is expressed at very low levels in -cells, all previous work on Mist1 has indicated that the protein is limited to the exocrine compartment of the pancreas (Pin et al. 2000 , 2001 , Rukstalis et al. 2003 , Zhu et al. 2004 ), which we have confirmed here during development. Therefore, Mist1 would not be able to directly affect transcription of the Glut-2 gene. Western-blot analysis revealed a decrease in Glut-2 protein by 2 months in Mist1 KO mice, suggesting that the loss of Glut-2 is not a primary defect in Mist1 KO mice, but likely a secondary effect. The fact that a change in Glut-2 expression was not observed by IF analysis in 2-month-old mice is likely due to the fact that IF reflects only qualitative aspects of protein expression, such as localization, and is not an accurate reflection of protein levels. The progressive loss of Glut-2 protein could reflect changes in the endocrine cell compartment due to long-term exposure to the altered exocrine compartment of Mist1 KO mice. Alternatively, -cell renewal may be compromised with replacement cells not able to reach full functional maturity. Based on previous reports, 98% of the -cells would be replaced within the time frame of this experiment (i.e. 10 months; Dor et al. 2004) . If a deficiency in Glut-2 staining was the result of replacement -cells not expressing Glut-2, one would expect patchy islet expression with some cells expressing normal Glut-2 levels and other cells expressing little to no Glut-2 expression. Given the uniform level of staining observed for Glut-2 in both young and older Mist1 KO mice, we believe that the decreases represent a general decrease in Glut-2 accumulation in all islet cells. (Pin et al. 2001) , a factor involved in islet regeneration and -cell proliferation (Akiyama et al. 2001 , Unno et al. 2002 . Whether Reg1 is protective of the islets in a damaging exocrine environment or reflective of islet damage is unclear. However, there is no increase in the proliferation rate of islet cells in the absence of Mist1 expression in 10-month-old mice. In addition, we have identified extensive tissue remodeling based on matrix metalloproteinase (MMP) activation in Mist1 KO pancreatic tissue (data not shown). Increased MMP activity has been linked to increased islet neogenesis in Pdx1/Pbx1 double heterozygous mice which develop age-dependent overt diabetes mellitus . The increase in MMP activity may also be reflective of the general deterioration of the exocrine compartment in 10-month-old Mist1 KO mice. In conclusion, we have now identified specific biochemical and functional alterations that occur in endocrine pancreatic tissue following deletion of an exocrine-specific transcription factor. This study implies that a complex paracrine environment exists between the tissues that are necessary for functional maturation. Disruptions in this environment would have implications on the function and susceptibility for disease for both the exocrine and endocrine pancreas.
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